203 related articles for article (PubMed ID: 7522105)
1. News from "the real world": cost-effectiveness in palliative care.
Support Care Cancer; 1994 Jul; 2(4):211-2. PubMed ID: 7522105
[No Abstract] [Full Text] [Related]
2. Cost aspects of palliative cancer care.
Bailes JS
Semin Oncol; 1995 Apr; 22(2 Suppl 3):64-6. PubMed ID: 7537906
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy in Medicare-certified freestanding hospices.
Jarosek SL; Virnig BA; Feldman R
J Pain Symptom Manage; 2009 May; 37(5):780-7. PubMed ID: 18789642
[TBL] [Abstract][Full Text] [Related]
4. Why managed care should provide supportive therapies for cancer patients.
Rubenstein SA
Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
[No Abstract] [Full Text] [Related]
5. Hospital-based palliative care: cost-effective care for patients with advanced disease.
Stephens S
J Nurs Adm; 2008 Mar; 38(3):143-5. PubMed ID: 18327063
[TBL] [Abstract][Full Text] [Related]
6. Can treatment costs be tamed?
Malakoff D
Science; 2011 Mar; 331(6024):1545-7. PubMed ID: 21436438
[No Abstract] [Full Text] [Related]
7. Palliative care in Minnesota.
Thalhuber W
Minn Med; 2000 May; 83(5):52-3. PubMed ID: 10832317
[No Abstract] [Full Text] [Related]
8. [Economic effects of "molecular" medicine].
Riemann JF
Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
[No Abstract] [Full Text] [Related]
9. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
Tirelli U; Berretta M; Bearz A; Carbone A
Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1355-6. PubMed ID: 22195374
[No Abstract] [Full Text] [Related]
10. Economic appraisal in health care with particular reference to hospice and palliative care.
Boldy D
Aust Health Rev; 1989; 12(2):72-6. PubMed ID: 10315782
[TBL] [Abstract][Full Text] [Related]
11. Trends in Provision of Palliative Radiotherapy and Chemotherapy Among Hospices in the United States, 2011-2018.
Hsu SH; Wang SY
JAMA Oncol; 2020 Jul; 6(7):1106-1108. PubMed ID: 32352492
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of home/hospice palliative and supportive care.
Hill LT
J Natl Cancer Inst; 1994 Jan; 86(1):63-4. PubMed ID: 7505831
[No Abstract] [Full Text] [Related]
13. [The Dutch Health Council report on palliative chemotherapy: possible confusion on ideas].
Verweij J; de Mulder PH; Pinedo HM
Ned Tijdschr Geneeskd; 2004 Apr; 148(14):651-4. PubMed ID: 15106314
[TBL] [Abstract][Full Text] [Related]
14. [Innovative therapy, early and cost-benefit assessment].
Dierks C
Onkologie; 2012; 35 Suppl 2():7. PubMed ID: 22517064
[No Abstract] [Full Text] [Related]
15. Medicare cost containment strategy targets several oncology drugs.
Twombly R
J Natl Cancer Inst; 2004 Sep; 96(17):1268-70. PubMed ID: 15339960
[No Abstract] [Full Text] [Related]
16. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
17. A cost analysis of hospice versus non-hospice care: positioning characteristics for marketing a hospice.
Oji-McNair K
Health Mark Q; 1985; 2(4):119-29. PubMed ID: 10311206
[No Abstract] [Full Text] [Related]
18. Don't deny the economics. Hospice and palliative care are best for chronic illness, controlling costs.
Adelus S
Mod Healthc; 2012 Jul; 42(30):25. PubMed ID: 22950262
[No Abstract] [Full Text] [Related]
19. Cost savings in cancer care from the selection of effective versus ineffective initial chemotherapy.
Dickinson KD; Myers TJ
Prog Clin Biol Res; 1990; 339():465-76. PubMed ID: 2118261
[No Abstract] [Full Text] [Related]
20. The price of palliative care: toward a complete accounting of costs and benefits.
Boni-Saenz AA; Dranove D; Emanuel LL; Lo Sasso AT
Clin Geriatr Med; 2005 Feb; 21(1):147-63, ix. PubMed ID: 15639042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
